130 related articles for article (PubMed ID: 22329022)
1. Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity.
Shane BS; Zeiger E; Piegorsch WW; Booth ED; Goodman JI; Peffer RC
Environ Mol Mutagen; 2012 Jan; 53(1):1-9. PubMed ID: 22329022
[TBL] [Abstract][Full Text] [Related]
2. Response to commentary: "Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity".
Ross JA; Leavitt SA
Environ Mol Mutagen; 2012 Aug; 53(7):574-7. PubMed ID: 22829338
[No Abstract] [Full Text] [Related]
3. Quantitative changes in endogenous DNA adducts correlate with conazole in vivo mutagenicity and tumorigenicity.
Ross JA; Leavitt SA; Schmid JE; Nelson GB
Mutagenesis; 2012 Sep; 27(5):541-9. PubMed ID: 22492202
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
5. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine.
Nicolette J; Murray J; Sonders P; Kondratiuk A; Crosby M
Environ Mol Mutagen; 2021 Jan; 62(1):4-17. PubMed ID: 32951273
[TBL] [Abstract][Full Text] [Related]
7. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
Cunningham ML; Hayward JJ; Shane BS; Tindall KR
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of furan in female Big Blue B6C3F1 mice.
Terrell AN; Huynh M; Grill AE; Kovi RC; O'Sullivan MG; Guttenplan JB; Ho YY; Peterson LA
Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():46-54. PubMed ID: 25344163
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
[TBL] [Abstract][Full Text] [Related]
10. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
12. Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue transgenic mice.
Shane BS; Smith-Dunn DL; deBoer JG; Glickman BW; Cunningham ML
Mutat Res; 2000 Mar; 448(1):69-80. PubMed ID: 10751624
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mutations induced by conazole fungicides in vivo.
Ross JA; Leavitt SA
Mutagenesis; 2010 May; 25(3):231-4. PubMed ID: 20064898
[TBL] [Abstract][Full Text] [Related]
14. In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice.
Itoh T; Suzuki T; Nishikawa A; Furukawa F; Takahashi M; Xue W; Sofuni T; Hayashi M
Mutat Res; 2000 Jun; 468(1):19-25. PubMed ID: 10863154
[TBL] [Abstract][Full Text] [Related]
15. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
Bielas JH
Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic characterization of the transgenic Big Blue Rat2 and Big Blue mouse embryonic fibroblast cell lines.
Erexson GL; Cunningham ML; Tindall KR
Mutagenesis; 1998 Nov; 13(6):649-53. PubMed ID: 9862199
[TBL] [Abstract][Full Text] [Related]
17. Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action.
Currie RA; Peffer RC; Goetz AK; Omiecinski CJ; Goodman JI
Toxicology; 2014 Jul; 321():80-8. PubMed ID: 24675475
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
19. Mutation studies with dimethyl nitrosamine in young and old lac I transgenic mice.
Tinwell H; Lefevre PA; Ashby J
Mutat Res; 1994 Jun; 307(2):501-8. PubMed ID: 7514724
[TBL] [Abstract][Full Text] [Related]
20. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
Shane BS; deBoer JG; Glickman BW; Cunningham ML
Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
